Eugene R. Bleecker

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung, Sally E. Wenzel, Jan Brożek et al. · European Respiratory Journal · 2013 · 3.9K citations · Full text

Medicine, Internal Medicine, Pediatrics +13

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Ian Pavord, Stephanie Korn, Peter Howarth et al. · The Lancet · 2012 · 2.2K citations

Life Sciences, Internal Medicine, Pharmacotherapy +14

Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

Wendy C. Moore, Deborah A. Meyers, Sally E. Wenzel et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 2.1K citations

Public Health, Pharmacotherapy, Allergy +16

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Eugene R. Bleecker, J. Mark FitzGerald, Pascal Chanez et al. · The Lancet · 2016 · 1.4K citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair et al. · The Lancet · 2016 · 1.4K citations

Pharmacy, Immunology, Pharmacology +17